+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sjogren Syndrome Drug"

Sjogren's syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Sjogren's syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Sjogrens Syndrome Therapeutics Market 2024-2028 - Product Thumbnail Image

Sjogrens Syndrome Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 160 Pages
  • Global
From
From
Sjogren's Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sjogren's Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Sjogren Syndrome is an autoimmune disorder that affects the body's ability to produce tears and saliva. It is characterized by dry eyes and dry mouth, and can lead to other complications such as fatigue, joint pain, and difficulty swallowing. Treatment for Sjogren Syndrome typically involves medications to reduce inflammation, increase saliva production, and improve tear production. Immune Disorders Drugs are a class of medications used to treat autoimmune disorders such as Sjogren Syndrome. These drugs work by suppressing the immune system, which helps to reduce inflammation and improve symptoms. Common Immune Disorders Drugs used to treat Sjogren Syndrome include corticosteroids, antimalarials, and biologics. The Sjogren Syndrome Drug market is a subset of the larger Immune Disorders Drugs market. It is composed of companies that specialize in the development and manufacture of medications used to treat Sjogren Syndrome. Some of the companies in the Sjogren Syndrome Drug market include AbbVie, Amgen, AstraZeneca, Biogen, and Novartis. Show Less Read more